New combo therapy aims to tackle Tough-to-Treat myeloma
NCT ID NCT05137054
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental drug called linvoseltamab combined with other cancer treatments for people with multiple myeloma that has come back after previous therapy. The main goal is to see if the combinations are safe and to find the right dose. About 317 participants will be enrolled, and researchers will also check if the tumors shrink or disappear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
linvoseltamab (also called REGN5458) plus other cancer drugs (daratumumab, carfilzomib, lenalidomide, bortezomib)
What this could lead to
If successful, this could lead to a new combination treatment option for patients with multiple myeloma that has returned after prior therapies.
What could go wrong
This is an early Phase 1b study focused on safety and dosing, so it is too soon to know if the combinations will work. Side effects from the drugs are possible, and the trial is small.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Montpellier - Departement D'Hematologie
RECRUITINGMontpellier, 34295, France
-
CHU de Lille - Rue Michel Polonovski
SUSPENDEDLille, Nord, 59037, France
-
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITINGPoitiers, New Aquitaine, 86021, France
-
Centre Hospitalier Universitaire Angers
RECRUITINGAngers, 49933, France
-
Clinica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Clinica Universidad de Navarra - Madrid
RECRUITINGMadrid, 28027, Spain
-
Dana Farber/Harvard Cancer Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
Evangelismos General Hospital
RECRUITINGAthens, Attica, 10676, Greece
-
General Hospital of Athens Alexandra
RECRUITINGAthens, 11528, Greece
-
Hadassah Medical Center
RECRUITINGJerusalem, 91120, Israel
-
Hopital Necker
RECRUITINGParis, Île-de-France Region, 75015, France
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital Clinico Universitario de Santiago
RECRUITINGSantiago de Compostela, A Coruna, 15706, Spain
-
Hospital Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
-
Hospital Henri Mondor
RECRUITINGCréteil, Île-de-France Region, 94000, France
-
Hospital Universitario HM Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
Hospital Universitario Marques de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital Universitario Quiron Salud Madrid
RECRUITINGPozuelo de Alarcón, Madrid, 28223, Spain
-
Hospital Universitario Ramon y Cajal - Servicio de Psiquiatria
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Indiana University Health Simon Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
-
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals,
RECRUITINGBarcelona, 08908, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Nantes University Hospital
RECRUITINGNantes, Pays de la Loire Region, 44093, France
-
New York Presbyterian Hospital Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Rambam Health Care Campus
RECRUITINGHaifa, 3109601, Israel
-
Saint Antoine Hospital
RECRUITINGParis, 75571, France
-
Saint Louis Hospital
RECRUITINGParis, Île-de-France Region, 75010, France
-
Scripps Clinic Torrey Pines
RECRUITINGLa Jolla, California, 92037, United States
-
Sheba Medical Center
RECRUITINGRamat Gan, Central District, 5265601, Israel
-
The Ohio State University James Cancer Hospital
RECRUITINGColumbus, Ohio, 43210, United States
-
Universitaru Hospital La Princesa
RECRUITINGMadrid, 28006, Spain
-
University Hospital and Research Institute
RECRUITINGMadrid, 28041, Spain
-
University Hospital of Salamanca
RECRUITINGSalamanca, 37007, Spain
-
University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
-
VA Puget Sound Health Care System
RECRUITINGSeattle, Washington, 98108, United States
-
Wake Forest University Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Weill Cornell Medicine/New York Presbyterian Hospital
RECRUITINGNew York, New York, 10021, United States
-
Winship Cancer Institute of Emory University
RECRUITINGAtlanta, Georgia, 30004, United States